New Journey announced that the company or its subsidiary plans to use a total of 437 million yuan of its own and self-raised funds to acquire a 51% stake in Shandong Zepu Medical Technology Co., Ltd. through equity transfer and capital increase. Of this, 130 million yuan will be used to acquire a 23.64% stake in Zepu Medical, while 307 million yuan will be injected into Zepu Medical as a capital increase. After the transaction is completed, Zepu Medical will be included in New Journey's consolidated financial statements, and goodwill of approximately 210 million to 240 million yuan is expected to be formed. Zepu Medical is an enterprise engaged in the research, development, production, sales and service of intelligent rehabilitation medical equipment, and has obtained 31 domestic Class II medical device registration certificates, including 8 intelligent rehabilitation products. The transaction has been approved by New Journey's board of directors and does not need to be submitted to the shareholders' meeting for review. It still needs to complete the industrial and commercial registration change of the target equity, and there is uncertainty as to whether it can ultimately be completed.
Hengkang Medical Group Co LtdNew Journey acquires 51% stake for 437 million yuan, valuing Zepu Medical and providing capital injection.
